← Back to patent-cliff list
ALN-PNP
Tier C — Watch / tradeALN-PNP
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Nucleic acid drug
Type
Targets：1-acylglycerol-3-phosphate O-acyltransferase PNPLA3
Indications (approved)：Non-alcoholic steatohepatitis
Regional status
US
Phase II
2022-12-27
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of ALN-PNP?
Approved indications include: Non-alcoholic steatohepatitis.
When does the ALN-PNP patent expire?
No public expiry year is available for ALN-PNP yet; this page updates once verified.
How do I get a quote for ALN-PNP intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03